Infections caused by Candida species, constitute serious risk to the patients, particularly hospitalized in intensive care units. In this study, typing and amphotericin B, fluconazole, voriconazole and flucytosine susceptibility of Candida species isolated from blood cultures were aimed to be investigated retrospectively. Yeasts detected from blood cultures in our laboratory between January 2009 and December 2012 were typed by germ tube and VITEK 2 Compact System (BioMérieux, Fransa) automated identification system and susceptibilities to antifungal agents were determined. The distribution of detected overall 58 candida species was as follows: Candida albicans (57 %), Candida parapsilosis (14 %), Candida tropicalis (14 %), Candida glabrata (10 %) and Candida guilliermondi (5 %). It was seen that among patients included into the study, 78 % were hospitalized in intensive care units and 70 % were elderly (geriatric) patients. It was determined among isolated Candida species that one C.guilliermondii strain was resistant to amphotericin B and fluconazole, two C.albicans strains were intermediately susceptible to amphotericin B, one C.glabrata strain was intermediately susceptible to flucytosine and fluconazole and one C.tropicalis strain was intermediately susceptible to fluconazole. As a result of our study, in which Candida species detected were resistant and moderately susceptible to antifungal agents, subtyping and determining antifungal susceptibilities of candida species isolated from blood cultures is concluded to be important to direct the treatment, especially in neonates, elderly patients and intensive care unit patients.